OUTLOOK THERAPEUTICS
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $9 | $127 | $-1,207 | $-91 |
Gross Profit | -8 | -21 | -1,237 | -1,008 |
EBITDA | -20,278 | -13,996 | -13,453 | -14,553 |
EBIT | -20,217 | -14,026 | -13,483 | -14,583 |
Net Income | -20,319 | -4,453 | -23,058 | -13,292 |
Net Change In Cash | 9 | 127 | -1,207 | -91 |
Free Cash Flow | -21,988 | -7,828 | -14,939 | -12,377 |
Cash | 11,242 | 7,748 | 8,677 | 8,083 |
Basic Shares | 25,476 | 25,476 | 25,476 | 25,476 |
Annual Financials
| Values in thousands | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
Revenue | $1,413 | $170 | $0 | $0 |
Gross Profit | 657 | -113 | -44 | -204 |
EBITDA | -63,576 | -72,093 | -56,404 | -64,357 |
EBIT | -63,693 | -72,206 | -56,448 | -64,562 |
Net Income | -62,424 | -75,366 | -58,982 | -66,052 |
Net Change In Cash | 1,413 | 170 | 0 | 0 |
Cost of Revenue | 2,919 | |||
Free Cash Flow | -51,829 | -68,793 | -42,973 | -56,674 |
Cash | 8,083 | 14,927 | 23,391 | 17,396 |
Basic Shares | 25,476 | 18,549 | 12,508 | 10,604 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.09 |
2026-03-31 | -$0.17 |
2025-12-31 | -$0.22 |
2025-09-30 | -$0.28 |